The Editor-in-Chief has retracted this article [1] because, contrary to the statement in the article, the authors have been unable to provide documents confirming that ethics approval was obtained for the study. The ethics committee of Tianjin Medical University Cancer Institute and Hospital has confirmed that it did not approve this study. All authors agree to this retraction.
Reference
Liu L, Hu Y, Zhang S, et al. Association of insulin-like growth factor 1 receptor and estrogen receptor with pathological complete response to neoadjuvant chemotherapy in HER2-negative breast cancer. Breast Cancer. 2019. https://doi.org/10.1007/s12282-018-00939-y.
Author information
Authors and Affiliations
Corresponding authors
Additional information
The Editor-in-Chief has retracted this article [1] because, contrary to the statement in the article, the authors have been unable to provide documents confirming that ethics approval was obtained for the study. The ethics committee of Tianjin Medical University Cancer Institute and Hospital has confirmed that it did not approve this study. All authors agree to this retraction. [1] Liu, L., Hu, Y., Zhang, S. et al. Association of insulin-like growth factor 1 receptor and estrogen receptor with pathological complete response to neoadjuvant chemotherapy in HER2-negative breast cancer. Breast Cancer. 2019. https://doi.org/10.1007/s12282-018-00939-y
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Liu, L., Hu, Y., Zhang, S. et al. RETRACTED ARTICLE: Association of insulin-like growth factor 1 receptor and estrogen receptor with pathological complete response to neoadjuvant chemotherapy in HER2-negative breast cancer. Breast Cancer 26, 854 (2019). https://doi.org/10.1007/s12282-018-00939-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12282-018-00939-y